KHashmi317 Posted December 16, 2016 Report Share Posted December 16, 2016 "Changes to gene activity that occur with age can be turned back, a new study shows ..." By Karen Weintraub on December 15, 2016 https://www.scientificamerican.com/article/aging-is-reversible-at-least-in-human-cells-and-live-mice/# Have only skimmed this new article, so I won't comment. Link to comment Share on other sites More sharing options...
AlPater Posted December 16, 2016 Report Share Posted December 16, 2016 It seems to me to be an impressive feat. I kind of agree with Kaeberlein, though. You can read the full text yourself: In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming Online Extra Alejandro Ocampo, Pradeep Reddy, Paloma Martinez-Redondo, Aida Platero-Luengo, Fumiyuki Hatanaka, Tomoaki Hishida, Mo Li, David Lam, and others Cell, Vol. 167, Issue 7, p1719–1733.e12 Published in issue: December 15, 2016 http://www.cell.com/cell/fulltext/S0092-8674(16)31664-6 Highlights •Partial reprogramming erases cellular markers of aging in mouse and human cells •Induction of OSKM in progeria mice ameliorates signs of aging and extends lifespan •In vivo reprogramming improves regeneration in 12-month-old wild-type mice Summary Aging is the major risk factor for many human diseases. In vitro studies have demonstrated that cellular reprogramming to pluripotency reverses cellular age, but alteration of the aging process through reprogramming has not been directly demonstrated in vivo. Here, we report that partial reprogramming by short-term cyclic expression of Oct4, Sox2, Klf4, and c-Myc (OSKM) ameliorates cellular and physiological hallmarks of aging and prolongs lifespan in a mouse model of premature aging. Similarly, expression of OSKM in vivo improves recovery from metabolic disease and muscle injury in older wild-type mice. The amelioration of age-associated phenotypes by epigenetic remodeling during cellular reprogramming highlights the role of epigenetic dysregulation as a driver of mammalian aging. Establishing in vivo platforms to modulate age-associated epigenetic marks may provide further insights into the biology of aging. Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.